Cherry Tree Wealth Management, LLC Halozyme Therapeutics, Inc. Transaction History
Cherry Tree Wealth Management, LLC
- $415 Billion
- Q1 2025
A detailed history of Cherry Tree Wealth Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Cherry Tree Wealth Management, LLC holds 52 shares of HALO stock, worth $3,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52Holding current value
$3,152% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
576Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.07 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$778 Million0.02% of portfolio
-
State Street Corp Boston, MA7.18MShares$436 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$253 Million4.34% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$236 Million0.05% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.44B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...